Plain-English translation of NCT05099939 on ClinicalTrials.gov ↗ · Source last updated ·
Researchers want to understand whether continuous glucose monitoring—a small device that tracks blood sugar levels around the clock—can help predict how cystic fibrosis will affect your lungs and overall health over time. This is an observational study, meaning you won't be taking any new medication; instead, researchers will carefully track your blood sugar patterns and clinical health for five years to see which patterns are most closely linked to changes in lung function.
People with cystic fibrosis often develop blood sugar problems, but doctors aren't sure exactly which blood sugar patterns are warning signs of declining lung health. This study aims to fill that gap by learning whether continuous glucose monitoring can help predict which patients are at risk for faster lung function decline—information that could guide better, more personalized care in the future.
You likely qualify if…
You likely don't qualify if…
You will visit the research center three times over two years (at enrollment, one year later, and two years later) to wear a continuous glucose monitor for 14 days each time. The monitor is a small sensor that tracks your blood sugar continuously and requires no injections or blood draws—you simply wear it on your skin and return it after two weeks. The research team will also review your medical records from the two years before you enroll and for one year after your final visit, tracking changes in your lung function, nutrition, and overall health.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Canada
France